Benefits and Risks of Torasemide in Congestive Heart Failure and Essential Hypertension
- 1 February 1996
- journal article
- research article
- Published by Springer Nature in Drug Safety
- Vol. 14 (2) , 104-120
- https://doi.org/10.2165/00002018-199614020-00005
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Effect of Diuretics on Morbidity and Mortality in the Treatment of HypertensionCardiology, 1994
- Tubular Effects of the Diuretic TorasemideCardiology, 1994
- Symptomatic Achievements with Diuretics in Congestive Heart FailureCardiology, 1994
- Efficacy and Tolerance of Low-Dose Loop Diuretics in HypertensionCardiology, 1994
- Renal and extrarenal sites of action of diureticsCardiovascular Drugs and Therapy, 1993
- Diuretics and cardiovascular risk factorsEuropean Heart Journal, 1992
- Anti-aldosteronergic effect of torasemideEuropean Journal of Pharmacology, 1991
- TorasemideDrugs, 1991
- Clinical Pharmacology of Loop DiureticsDrugs, 1991
- Furosemide kinetics and dynamics in aged patientsClinical Pharmacology & Therapeutics, 1983